Xeris Biopharma Holdings, Inc. XERS Increase (Decrease) in Prepaid Expense
Increase (Decrease) in Prepaid Expense at other companies
Other financials
Where this comes from
Reported directly by Xeris Biopharma Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInPrepaidExpense.
The official record: Xeris Biopharma Holdings, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Xeris Biopharma Holdings, Inc.'s increase (decrease) in prepaid expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Xeris Biopharma Holdings, Inc.'s increase (decrease) in prepaid expense?
- Xeris Biopharma Holdings, Inc. (XERS) reported increase (decrease) in prepaid expense of -$145K in Q1 2026.
- How has Xeris Biopharma Holdings, Inc.'s increase (decrease) in prepaid expense changed year-over-year?
- Xeris Biopharma Holdings, Inc.'s increase (decrease) in prepaid expense increased by 90.5% year-over-year, from -$1.53M to -$145K.
- What is the long-term trend for Xeris Biopharma Holdings, Inc.'s increase (decrease) in prepaid expense?
- Over 2 years (2021 to 2023), Xeris Biopharma Holdings, Inc.'s increase (decrease) in prepaid expense has grown at a -1.3% compound annual growth rate (CAGR), from -$3.29M to -$3.21M.